A Study to Test Different Doses of BI 1358894 and Find Out Whether They Reduce Symptoms in People With Borderline Personality Disorder

PHASE2CompletedINTERVENTIONAL
Enrollment

390

Participants

Timeline

Start Date

November 13, 2020

Primary Completion Date

December 9, 2022

Study Completion Date

January 25, 2023

Conditions
Borderline Personality Disorder
Interventions
DRUG

BI 1358894

Film-coated tablet

DRUG

Placebo

Film-coated tablet

Trial Locations (67)

1431

"University Multiprofile Hospital for Active Treatement Alexandrovska EAD", Sofia

1680

Medical Center Intermedica Ltd., Sofia

1900

Clinica Privada de Salud Mental Santa Teresa de Avila, La Plata

Instituto de Neurociencias San Agustín, La Plata

2000

Instituto Médico de la Fundación Estudios Clínicos, Rosario

2570

Universitair Psychiatrisch Centrum Duffel (UPC Duffel), Duffel

3004

Monash Alfred Psychiatry Research Centre, Melbourne

3199

Peninsula Therapeutic and Research Group, Frankston

4000

"Filipopolis - Ambulatory for Group Practice for Specialized Care in Psychiatry", Plovdiv

4600

Region Zealand, Psychiatric Research Unit, Slagelse

5004

CEN (Centro Especializado Neurociencias), Córdoba

9000

Aalborg Universitetsshospital, Aalborg

10000

Clintrial s.r.o., Prague

11516

Neurobehavioral Research, Inc., Cedarhurst

12203

Charité - Universitätsmedizin Berlin, Berlin

14215

University at Buffalo, The State University of New York, Buffalo

18600

INEP medical s.r.o., Prague

25125

IRCCS San Giovanni Di Dio Fatebenefratelli, Brescia

30022

Institute for Advanced Medical Research, Alpharetta

32607

Sarkis Clinical Trials, Gainesville

33014

San Marcus Research Clinic, Inc., Miami

33912

Gulf Coast Clinical Research Center, Fort Myers

34295

HOP la Colombière, Montpellier

35385

Universitätsklinikum Gießen und Marburg GmbH, Giessen

39008

Hospital Universitario Marqués de Valdecilla, Santander

39232

Precise Research Centers, Flowood

41013

Hospital Virgen del Rocío, Seville

47007

CS Casa del Barco, Valladolid

52074

Universitätsklinikum Aachen, AöR, Aachen

53127

Universitätsklinikum Bonn AöR, Bonn

64460

Hospital Universitario Dr Jose Eleuterio Gonzalez, Monterrey

64610

CIT-Neuropsique S.C, Monterrey

68159

Zentralinstitut für seelische Gesundheit, Mannheim

69677

HOP Pierre Wertheimer, Bron

72076

Universitätsklinikum Tübingen, Tübingen

74136

Central States Research, LLC, Tulsa

76000

Centro de Estudios Clinicos de Queretaro S.C, Querétaro

76309

Grayline Research Center, Wichita Falls

78213

BIND Investigaciones S.C., San Luis Potosí City

80336

Klinikum der Universität München - Campus Innenstadt, München

91786

Pacific Clinical Research Management Group LLC, Upland

92591

Viking Clinical Research, Ltd., Temecula

92805

Advanced Research Center, Inc., Anaheim

97070

Medical Care & Research SA de CV, Mérida

98201

Core Clinical Research, Everett

06519

Yale University School of Medicine, New Haven

02478

McLean Hospital, Belmont

08002

Center For Emotional Fitness, Cherry Hill

C1133AAH

Fundación para el Estudio y Tratamiento de las Enfermedades Mentales (FETEM), CABA

C1405BOA

Fundación FunDaMos para la asistencia e investigación en psiquiatría, CABA

X5000FAL

Instituto Modelo de Neurología Lennox, Córdoba

X5003DCE

Instituto Médico DAMIC S.R.L., Córdoba

S2000QJI

Centro de Investigacion y Asistencia en Psiquiatria (CIAP), Rosario

708 68

MPMeditrine s.r.o., Ostrava-Poruba

815-0071

Kokoro no Clinic Hirao, Fukuoka, Fukuoka

830-0033

Hirota Clinic, Fukuoka, Kurume

214-0014

Kishiro Mental Clinic, Kanagawa, Kawasaki

223-0062

Hiyoshi Hospital, Kanagawa, Yokohama

634-8522

Nara Medical University Hospital, Nara, Kashihara

103-0012

i Kokoro Clinic Nihonbashi, Tokyo, Chuo-ku

162-0843

Ichigaya Himorogi Clinic, Tokyo, Shinjuku-ku

07000

GabiPros S.C., Mexico City

15-732

Podlassian Center of Psychogeriatry, Bialystok, Bialystok

80-546

PI HOUSE Sp. z o.o., Gdansk, Gdansk

122 31

Psykiatri Södra Stockholm, Enskede

416 50

Sahlgrenska Universitetssjukhuset, Östra, Gothenburg

751 85

Akademiska sjukhuset, Uppsala

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT04566601 - A Study to Test Different Doses of BI 1358894 and Find Out Whether They Reduce Symptoms in People With Borderline Personality Disorder | Biotech Hunter | Biotech Hunter